Abstract:Gene carriers made from polylysine are of interest in relation to gene therapy but suffer from the lack of transfection efficiency due to limited stability and endosomal escape ability. To address this problem, we designed and developed Schiff-base linked imidazole modified polylysine with a reversible-PEGylation catiomer (SL-ImPEG-SS-PLL) for high efficiency gene delivery. The reversible PEGylation was introduced for in vivo circulation, as well as selective PEG detachment to augment the cellular internalization, while introducing Schiff-base linked imidazole residues into polylysine was expected to accelerate the endosomal escape of the DNA payload, as well as facilitate intracellular DNA unpacking and release, thus significantly enhancing gene delivery efficiency. The size alteration of the SL-I15mPEG-SS-PLL/pDNA polyplexes in the presence of 10 mM GSH suggests stimulus-induced PEG detachment under tumor relevant reduction conditions. Acid-base titration assays indicate that imidazole residues confer on polylysine remarkable buffering ability. The agarose gel retardation assay suggests that the Schiff-base linkages provide an increased DNA binding ability to protect DNA against nucleases and timely intracellular DNA unpacking to permit DNA dissociation from polylysine and access to transcriptional machinery. Biological efficacy assessment of this multifunctional carrier, using pEGFP and pGL-3 as reporter genes, indicates comparable to or even higher transfection efficiencies than gold standard PEI and their transfection efficiencies are slightly affected by serum. More importantly, in vivo transfection of pEGFP reveals that GFP expression was found not only in some of the important organs, such as the liver, spleen, kidneys and lungs, but also in the transplanted carcinoma. These experimental results suggest that the reversible PEGylation and Schiff-base linked imidazole modification make SL-ImPEG-SS-PLL a great potential candidate for an effective and biocompatible gene delivery system.

Cleavable PEGylation and Hydrophobic Histidylation of Polylysine for Sirna Delivery and Tumor Gene Therapy.

Suppression of VEGF by reversible-PEGylated histidylated polylysine in cancer therapy.

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.

Gene Therapy: Suppression of VEGF by Reversible‐PEGylated Histidylated Polylysine in Cancer Therapy (Adv. Healthcare Mater. 11/2014)

Reversible PEGylation and Schiff-base linked imidazole modification of polylysine for high-performance gene delivery.

Copolymer of Poly(Ethylene Glycol) and Poly((L)-Lysine) Grafting Polyethylenimine Through A Reducible Disulfide Linkage for Sirna Delivery

Effective Tumor Treatment by Vegf Sirna Complexed with Hydrophobic Poly(Amino Acid)-Modified Polyethylenimine

Disulfide-Bridged Cleavable PEGylation of Poly-L-Lysine for SiRNA Delivery.

Enhanced Gene Delivery Efficiency of Cationic Liposomes Coated with PEGylated Hyaluronic Acid for Anti P-glycoprotein Sirna: A Potential Candidate for Overcoming Multi-Drug Resistance

Polycation-detachable Nanoparticles Self-Assembled from Mpeg-Pcl-g-ss-pdmaema for in Vitro and in Vivo Sirna Delivery.

Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing.

Harnessing the Peg-Cleavable Strategy to Balance Cytotoxicity, Intracellular Release and the Therapeutic Effect of Dendrigraft Poly-L-Lysine for Cancer Gene Therapy

Biologically Responsive Carrier-Mediated Anti-Angiogenesis Shrna Delivery for Tumor Treatment

Biodegradable Multiamine Polymeric Vector for Sirna Delivery.

Tumor Acidity-Sensitive Polymeric Vector for Active Targeted Sirna Delivery.

Ph Responsive Pegylation Through Metal Affinity for Gene Delivery Mediated by Histidine-Grafted Polyethylenimine

Novel Fluorinated Polycationic Delivery of Anti-Vegf Sirna for Tumor Therapy

Tyroserleutide-based Gene Vector for Suppressing VEGF Expression in Cancer Therapy

The Effect of Guanidinylation of PEGylated Poly(2-Aminoethyl Methacrylate) on the Systemic Delivery of Sirna

Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor Therapy